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Introduction. Pericardium involvement is unusual in Multiple myeloma (MM) (0.5%), with less than 25 cases recorded in rele-
vant literature. It is associated with poor prognosis. Treatment options described in the literature are pericardiocentesis with
intrapericardial bleomycin, and chemotherapy with very low response rates.
Case report. 67 year oldmale diagnosed in 2001withmultiplemyelomaBence-JonesKappa stage IIIB. Initial complete responsewas
obtained after treatment with VBCMP/VBAD and auto-TPH. In 2006 and 2008 progressions of MM were treated with three more
lines of chemotherapywith ﬁnal complete remission. In 2011, patient presented cardiogenic syncope and pericardial effusionwas
observed on transesophageal echocardiography (TEE). Twomonths later, CT scan andTEE showedpericardial effusionprogression
with heart cavities partial collapse. Pericadiocentesis was performed, and cytologyc examination revealed clearly plasma cells.
Subsequently, an instillation of intrapericardial bleomycin and systemic treatment with lenalidomide were performed. Later
TEE showed residual pericardial effusion and discontinuities in the edges of the pulmonary artery, suggesting mediastinic-
pericardial mass, conﬁrmed by MRI scan. The patient was referred to our department, where external beam radiotherapy on
the mass to a total dose of 30Gy by 3Gy per fraction was performed. In later revisions, MRI scan and TEE showed pericardial
effusion decreased and a marked shrinkaged of the cardiac lesion. Disease progressed to the kidney with the patient ultimately
suffering renal failure with hydroelectrolytic imbalance and medullary aplasia secondary to chemotherapy which resulted in
sepsis, leading to the death of the patient two months later.
Conclusion. Pericardial involvement by MM can generate a pericardial effusion that can evolve into pericardial tamponade, with a
very poor prognosis. In current publications there are no references to external radiotherapy as a treatment option. In this case
we used radiotherapy with favorable local results.
http://dx.doi.org/10.1016/j.rpor.2013.03.345
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Introduction. Primary small bowel non-Hodgkin lymphoma is uncommon. Primary gastrointestinal non-Hodgkin lymphoma is
4–20% of all lymphomas and small bowel lymphoma is 20–54% of all gastrointestinal non-Hodgkin lymphomas.
Methods. A 62 year-oldwomanpresentedwith abdominal pain and constipation asmain symptoms. She did not have B symptoms.
The patient underwent endoscopy with duodenal biopsy. The histologic ﬁndings shows low-grade follicular lymphoma. She
completed study with body CT and bone marrow biopsy. After endoscopic biopsy the patient was treated with three-dimensional
conformal radiation therapy. The ﬁeld included the volved duodenal portion, to a total dose of 30Gy (5×2Gy).
Results. The most common treatment has been surgical resection followed adjuvant chemotherapy, radiotherapy or both. This
case was an indolent disease and the patient preferred radiotherapy alone and delayed chemotherapy only in case of relapse.
With 9 months of follow-up, the patient is free of disease. She underwent endoscopy with biopsy four months after the treatment
and the histologic ﬁnding was negative. Acute side effect was grade I nausea and vomiting. The patient does not have late toxicity.
Conclusion. Radiation therapy for small bowel lymphoma is well tolerated and gives good local control. However to carry out this
treatment the lesion have to locate in a no mobile small bowel portion. Some lesions cannot be located by CT imaging, in this
cases ﬁducial markers placed during the endoscopy could help us to planning the treatment.
http://dx.doi.org/10.1016/j.rpor.2013.03.346
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Introduction. Orbital lymphomas constitute about 8% of extranodal lymphomas and 1% of NHL, usually affecting conjunctiva and
eyelids and rarely retrobulbar region. Optimal treatment is yet to be determined. RT, frequently used, is a treatment that offers
excellent local response rates allowing organ preservation.
Method. 74 year old male with clinical three-month history of mild left proptosis and diplopia. On examination was observed left
VI cranial nerve paresis and exophthalmos. Normal visual acuity and fundus. Orbits CT and MRI describes a 15×12×6mm left
intraorbital mass perfectly deﬁned, occupying half inferior orbital, hypointense, that contacts the posterior, temporal and inferior
pole of the eyeball (inferior rectus, inferior oblique and lacrimal gland) without inﬁltration signs. Transconjunctival approach to
left periorbital incisional biopsy was performed with pathology result: connective tissue inﬁltration by Marginal zone lymphoma
ofmucosa-associated lymphoid tissue (MALT). The patientwas treatedwith 3D conformal radiotherapywith TC support (1.25mm
